about
Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosusOccupations and exposures in the work environment as determinants for rheumatoid arthritisDeficiency of activating Fcγ-receptors reduces hepatic clearance and deposition of IC and increases CIC levels in mercury-induced autoimmunity.Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage.Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity.Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register.Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitisComorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis.Annual incidence of inflammatory joint diseases in a population based study in southern SwedenDynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosusCirculating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking.Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA projectAssociations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register.Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.Infections preceding early arthritis in southern Sweden: a prospective population-based study.Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register-Based Study of 4,010 Patients in Sweden.Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.Designed surface with tunable IgG density as an in vitro model for immune complex mediated stimulation of leukocytes.Hand function and activity limitation according to health assessment questionnaire in patients with rheumatoid arthritis and healthy referents: 5-year followup of predictors of activity limitation (The Swedish TIRA Project).Designing a decision support system for existing clinical organizational structures: considerations from a rheumatology clinic.Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.Circulating cartilage oligomeric matrix protein in juvenile idiopathic arthritis.Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.Anti-brush border antibodies (ABBA) in sera from patients with ulcerative proctocolitis and in sera with antibodies against Yersinia enterocolitica 0:3.Hydrophobic interaction between DNP-HSA and different tissue structures in vivo assessed by indirect immunofluorescence microscopy.Autoantibodies versus clinical symptoms in blood donors.Distribution of lactoferrin and 60/65 kDa heat shock protein in normal and inflamed human intestine and liver.Circulating and tissue immune complexes in mercury-treated mice.Hepatic immune complex elimination studied with FITC-labelled antigen.alpha(1) Antitrypsin deficiency in a patient with systemic vasculitis and primary Sjögren's syndrome.Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate.Immunoglobulins within the central nervous system in primary Sjögren's syndrome.Fucosylation of alpha1-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis.Inducible nitric oxide synthase is expressed in synovial fluid granulocytes.Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis.A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block.
P50
Q24793357-E3622BEC-15B1-4DBC-AE48-30695E7A1478Q28393821-5123C6DE-6F24-496B-817C-5F3DCCD2DF99Q33728412-B9C7DAAA-4A62-497D-A1FC-DEDBB5DB259CQ33877817-ACFEE053-548F-4BAE-BAAC-2C5D37BEB6E2Q34376222-C5C778F6-A905-4663-A214-0C5BEF3A9333Q34462918-192DAA27-6495-4C39-A736-455906A38070Q35052779-ADBE562A-3FBB-455B-8026-AAD1517A945BQ35549024-9457FD95-8791-4274-BBC1-E05C6BA84002Q35549831-5D1396F0-683E-4065-92D0-21511DAC2155Q35551002-303343BC-FA47-44D2-80E8-D54507E011F7Q36132325-6B39DA6A-4408-4745-AE46-0667A6F81A24Q36310689-06E22608-4B9C-42CF-AEA9-7D6B8D92E1B4Q36929564-AC31B985-EB42-426B-ACAB-5EA2468F8A1CQ36955351-0600203B-873D-4018-B0A8-E22961F2F1DDQ37256378-E7C3395F-068F-4099-9CC8-5954EB62288BQ37470470-A5FC084B-8A4B-447B-9FB7-91E502EDFD8DQ37870032-5358C22A-DF78-4495-839B-9D61F90D3240Q38533964-31F52D81-AB98-48EA-B8C5-3B8D8B6F17BDQ39177930-D4F8528A-FBCB-4200-A7CE-91B6A2B33C3EQ39218909-55254CE0-E8D8-4306-BA13-2F4C56DD4638Q39765063-5BE7E3A7-5ECD-4D9A-8671-916F83165525Q40242401-10CE23CA-01BD-4E41-9251-E58CC71F1BB5Q40275197-60E34C83-F016-4E7E-B65B-57B699BDA043Q40501745-1158A3EC-43D7-4DC2-A93C-5F8F2ACD5598Q40623037-3AFC0C7F-CA30-4DB8-8016-D80DE5766669Q41385841-1190DB1C-0603-4C89-8648-C46FD898A5DDQ41481940-EA9BDA62-1922-461F-B579-212F5058AF4BQ41522768-E326A513-8AE2-47AA-8DBE-A61113C0A490Q41562772-364D62B8-959F-47BA-8425-A77B0EF3491AQ41763784-9E2C07D2-4C31-45ED-BAC8-B3546AFAB6ABQ41928122-86E1B2BC-1FF6-42E3-9079-97BCD63E0A25Q41965094-AA02EF50-7BEF-48B0-9666-F7D21C2C414DQ41965727-EF441111-FCA2-4263-B756-F3634CDCFCD1Q42566424-99E54C90-4F71-4946-9DF5-112890E42F9EQ43050433-32A761E8-389A-42F8-A6D3-AF06BF1590EAQ43824054-ED6B22F5-5F7D-4CE2-91FB-E5E18F554AC6Q43868665-0B94E3B0-AB6C-43BB-9B59-8404F48A7884Q44150681-893F7050-52F0-41E9-827A-DFD9B653B059Q44331523-6591721D-C4C1-4485-A425-D31487C25D68Q44355666-294D010F-A15D-4C29-B97D-C57B5482AB64
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas Skogh
@ast
Thomas Skogh
@en
Thomas Skogh
@es
Thomas Skogh
@nl
Thomas Skogh
@sl
type
label
Thomas Skogh
@ast
Thomas Skogh
@en
Thomas Skogh
@es
Thomas Skogh
@nl
Thomas Skogh
@sl
prefLabel
Thomas Skogh
@ast
Thomas Skogh
@en
Thomas Skogh
@es
Thomas Skogh
@nl
Thomas Skogh
@sl
P1053
C-9692-2009
P106
P21
P31
P3829
P496
0000-0002-0153-9249